全文获取类型
收费全文 | 710234篇 |
免费 | 50325篇 |
国内免费 | 1326篇 |
专业分类
耳鼻咽喉 | 9268篇 |
儿科学 | 23308篇 |
妇产科学 | 17671篇 |
基础医学 | 110959篇 |
口腔科学 | 20134篇 |
临床医学 | 63896篇 |
内科学 | 135323篇 |
皮肤病学 | 16330篇 |
神经病学 | 49865篇 |
特种医学 | 26045篇 |
外国民族医学 | 76篇 |
外科学 | 106008篇 |
综合类 | 14811篇 |
现状与发展 | 2篇 |
一般理论 | 161篇 |
预防医学 | 51391篇 |
眼科学 | 16427篇 |
药学 | 54549篇 |
3篇 | |
中国医学 | 2332篇 |
肿瘤学 | 43326篇 |
出版年
2019年 | 5570篇 |
2018年 | 8013篇 |
2017年 | 6239篇 |
2016年 | 6995篇 |
2015年 | 7700篇 |
2014年 | 10455篇 |
2013年 | 15695篇 |
2012年 | 20878篇 |
2011年 | 21926篇 |
2010年 | 12963篇 |
2009年 | 12174篇 |
2008年 | 20329篇 |
2007年 | 21933篇 |
2006年 | 22301篇 |
2005年 | 20839篇 |
2004年 | 20382篇 |
2003年 | 19300篇 |
2002年 | 18822篇 |
2001年 | 36583篇 |
2000年 | 37143篇 |
1999年 | 30514篇 |
1998年 | 7633篇 |
1997年 | 6407篇 |
1996年 | 6663篇 |
1995年 | 6676篇 |
1994年 | 6138篇 |
1993年 | 5632篇 |
1992年 | 23199篇 |
1991年 | 23127篇 |
1990年 | 22525篇 |
1989年 | 22292篇 |
1988年 | 20242篇 |
1987年 | 19630篇 |
1986年 | 18675篇 |
1985年 | 17458篇 |
1984年 | 12794篇 |
1983年 | 10841篇 |
1982年 | 5941篇 |
1979年 | 11594篇 |
1978年 | 8165篇 |
1977年 | 6858篇 |
1976年 | 6622篇 |
1975年 | 7287篇 |
1974年 | 8531篇 |
1973年 | 8187篇 |
1972年 | 7710篇 |
1971年 | 7158篇 |
1970年 | 6914篇 |
1969年 | 6339篇 |
1968年 | 5809篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Access to these technologies in the UK is very variable. Some technologies are recommended by the National Institute for Health and Care Excellence, while others have not been appraised, and new technologies are emerging all the time. Additionally, different guidelines for adults and children further complicate access to diabetes technology in the transition from paediatric to adult care. Against this background, Diabetes UK and NHS England have brought together a multidisciplinary group of experts, including clinicians and people with diabetes, to develop this consensus guideline, combining the different technologies into a common pathway to aid clinical and policy decision‐making. We created a pathway that supports the incremental addition of technology as monotherapy and then dual therapy in the same way that we incrementally add in therapeutic agents to support people with Type 2 diabetes to achieve their personalized glycaemic targets. The pathway emphasizes the importance of structured education, specialist support and appropriate access to psychological therapies, as essential pillars for optimized use of diabetes‐related technology, and recommends the re‐evaluation of its use when the individual is unable either to use the technology appropriately or to achieve the intended outcomes. This pathway is endorsed by UK‐wide clinical and patient associations and we recommend that providers and commissioners use it to ensure the right individual with diabetes has access to the right technology in a timely way to help achieve better outcomes. 相似文献
83.
84.
85.
86.
Theodoros Kratimenos Constantine N. Antonopoulos Dimitrios Tomais Panagiotis Dedeilias Vasileios Patris Ilias Samiotis John Kokotsakis Dimosthenis Farsaris Michalis Argiriou 《Journal of vascular surgery》2019,69(4):996-1002.e3
Objective
The aim of the study was to present the results for patients with atherosclerotic aneurysm of the descending thoracic aorta (DTA) treated with a novel thoracic stent graft.Methods
A single-center retrospective review of prospectively collected data was performed. We extracted demographic variables as well as atherosclerotic comorbidities and operation-related and imaging-related data from patients' medical records. We estimated technical success rate, in-hospital and 30-day mortality, and mortality at the end of follow-up as well as complication and reintervention rate in our study cohort. Follow-up computed tomography angiography was performed after 1 month and 6 months and yearly thereafter.Results
A total of 30 patients (80% male; mean age, 73.7 ± 6.33 years) were treated with Ankura Thoracic Stent Graft (Lifetech, Shenzhen, China) for DTA aneurysm from February 2014 until June 2017. Technical success of the thoracic endovascular aortic repair (TEVAR) was 97% (29/30 patients). A surgical conduit was required in one patient; in three patients, we intentionally covered the left subclavian artery because of insufficient proximal landing zone. No aorta-related deaths were recorded during follow-up. During the early postoperative period, two patients (7%) with long DTA coverage developed paralysis or paraparesis, which immediately resolved after lumbar drainage. No renal complications requiring dialysis were observed. One patient (3%) developed postoperative pulmonary infection, whereas access site complications were 7%. Two symptomatic patients treated outside instructions for use (7%) developed early type IA endoleak and one patient (3%) developed type IB endoleak; type II endoleak was recorded in 3% of the study cohort. During the 30-day postoperative period, two patients died of non-TEVAR-related causes, one of gastrointestinal bleeding and the other of pulmonary infection. During a median follow-up of 31.7 (range, 38.4) months, two more patients also died of non-TEVAR-related causes, one of stroke from carotid artery disease and the other of motor vehicle trauma. In the rest of the cohort, no other adverse events were noted.Conclusions
This novel endograft showed early evidence of a safe, effective, and durable endoprosthesis for the treatment of DTA aneurysms. 相似文献87.
Suwarna Chakraborty Sunil Jamuna Tripathi B.N. Srikumar T.R. Raju B.S. Shankaranarayana Rao 《Brain stimulation》2019,12(3):752-766
Background
Major depressive disorder (MDD) is a multifactorial disease which often coexists with cognitive deficits. Depression-induced cognitive deficits are known to be associated with aberrant reward processing, neurochemical and structural alterations. Recent studies have shown that chronic electrical stimulation of brain reward areas induces a robust antidepressant effect. However, the effects of repeated electrical self-stimulation of lateral hypothalamus - medial forebrain bundle (LH-MFB) on depression-induced cognitive deficits and associated neurochemical and structural alterations in the prefrontal cortex (PFC) are unknown.Objectives
We investigated the effect of chronic rewarding self-stimulation of LH-MFB in neonatal clomipramine (CLI) model of depression. During adulthood, neonatal CLI and saline administered rats were implanted with bilateral electrodes stereotaxically in the LH-MFB and trained to receive intracranial self-stimulation (ICSS) for 14 days. The rats were tested for depressive-like behaviors, learning and memory followed by estimation of PFC volumes, levels of monoamines and its metabolites in the PFC.Results
We found that chronic ICSS of LH-MFB reverses CLI-induced behavioral despair and anhedonia. Interestingly, self-stimulation normalizes the impaired novel object and location recognition memory in CLI rats. The amelioration of learning impairments in CLI rats was associated with the reversal of volume loss and restoration of monoamine metabolism in the PFC.Conclusion
We demonstrated that repeated intracranial self-stimulation of LH-MFB ameliorates CLI-induced learning deficits, reverses altered monoamine metabolism and the atrophy of PFC. Our results support the hypothesis that chronic brain stimulation rewarding experience might be evolved as a potential treatment strategy for reversal of learning deficits in depression and associated disorders. 相似文献88.
89.
90.